Stay updated with breaking news from Positive Modulator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
STOCKHOLM, SWEDEN / ACCESSWIRE / August 2, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
Press release content from Accesswire. The AP news staff was not involved in its creation.
AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, today announced that an abstract on clinical study data with its leading drug ...
STOCKHOLM, SWEDEN / ACCESSWIRE / July 5, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
STOCKHOLM, SE / ACCESSWIRE / April 21, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule